Krishan K. Kohli

641 total citations
42 papers, 529 citations indexed

About

Krishan K. Kohli is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Krishan K. Kohli has authored 42 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Krishan K. Kohli's work include Pharmacogenetics and Drug Metabolism (20 papers), Analytical Chemistry and Chromatography (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). Krishan K. Kohli is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Analytical Chemistry and Chromatography (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). Krishan K. Kohli collaborates with scholars based in India, United States and France. Krishan K. Kohli's co-authors include James D. McKinney, Radha K. Dhiman, Yogesh Chawla, Jatinder K. Lamba, Phillip W. Albro, T. A. Venkitasubramanian, Rakesh Kochhar, Amarjit S. Chaudhry, Hasan Mukhtar and B. N. Gupta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Krishan K. Kohli

41 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krishan K. Kohli India 14 175 114 91 87 75 42 529
Margarita G. Ladona Spain 13 192 1.1× 164 1.4× 75 0.8× 34 0.4× 33 0.4× 20 524
Burke United States 12 173 1.0× 146 1.3× 85 0.9× 47 0.5× 39 0.5× 23 608
Ronald J. Gerson United States 12 187 1.1× 229 2.0× 112 1.2× 68 0.8× 234 3.1× 17 791
Shunsuke Iwano Japan 18 282 1.6× 183 1.6× 187 2.1× 58 0.7× 32 0.4× 26 580
J Loeper France 11 192 1.1× 98 0.9× 115 1.3× 135 1.6× 63 0.8× 54 623
Peter H. Bach United Kingdom 19 284 1.6× 338 3.0× 134 1.5× 44 0.5× 88 1.2× 70 1.1k
Mikio Doy Japan 16 86 0.5× 122 1.1× 187 2.1× 144 1.7× 191 2.5× 37 742
A. Al‐Bader Kuwait 15 66 0.4× 109 1.0× 56 0.6× 60 0.7× 95 1.3× 30 560
José M. Pellegrino Argentina 14 140 0.8× 126 1.1× 267 2.9× 94 1.1× 106 1.4× 34 562
Cécile Astre France 18 59 0.3× 218 1.9× 155 1.7× 43 0.5× 99 1.3× 27 701

Countries citing papers authored by Krishan K. Kohli

Since Specialization
Citations

This map shows the geographic impact of Krishan K. Kohli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishan K. Kohli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishan K. Kohli more than expected).

Fields of papers citing papers by Krishan K. Kohli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishan K. Kohli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishan K. Kohli. The network helps show where Krishan K. Kohli may publish in the future.

Co-authorship network of co-authors of Krishan K. Kohli

This figure shows the co-authorship network connecting the top 25 collaborators of Krishan K. Kohli. A scholar is included among the top collaborators of Krishan K. Kohli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishan K. Kohli. Krishan K. Kohli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aneja, Jitender, Debasish Basu, Surendra K. Mattoo, & Krishan K. Kohli. (2013). Metabolic Syndrome in Alcohol-dependent Men: A Cross-sectional Study. SHILAP Revista de lepidopterología. 35(2). 190–196. 10 indexed citations
2.
Chaudhry, Amarjit S., Rakesh Kochhar, & Krishan K. Kohli. (2009). Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians.. PubMed. 130(4). 437–43. 8 indexed citations
3.
Chaudhry, Amarjit S., Rakesh Kochhar, & Krishan K. Kohli. (2008). Genetic polymorphism of CYP2C19 & therapeutic response to proton pump inhibitors.. PubMed. 127(6). 521–30. 32 indexed citations
4.
Dhiman, Radha K., Pralay Sarkar, Arpita Sharma, et al.. (2004). Alterations in Gallbladder Emptying and Bile Retention in the Absence of Changes in Bile Lithogenicity in Postmenopausal Women on Hormone Replacement Therapy. Digestive Diseases and Sciences. 49(7-8). 1335–1341. 12 indexed citations
5.
Lamba, Jatinder K., Radha K. Dhiman, Rajinder Singh, & Krishan K. Kohli. (2001). Correlation between omeprazole hydroxylase and CYP2C19 genotype in North Indians. European Journal of Clinical Pharmacology. 57(9). 649–652. 10 indexed citations
6.
Ramana, Kota V. & Krishan K. Kohli. (1999). Effect of coadministration of antituberculous drugs on the hepatic drug metabolizing enzymes and oxidative stress in the mouse. Indian Journal of Pharmacology. 31(4). 299–305. 1 indexed citations
7.
Ramana, Kota V. & Krishan K. Kohli. (1998). Gene regulation of cytochrome P450--an overview.. PubMed. 36(5). 437–46. 14 indexed citations
8.
Lamba, Jatinder K., Radha K. Dhiman, & Krishan K. Kohli. (1998). Genetic polymorphism of the hepatic cytochrome P450 2C19 in North Indian subjects*. Clinical Pharmacology & Therapeutics. 63(4). 422–427. 28 indexed citations
9.
Puri, Veena & Krishan K. Kohli. (1997). Purification and Characterization of Dexamethasone Inducible Hepatic Cytochrome P450 Isozymes from Rhesus Monkey. Drug and Chemical Toxicology. 20(1-2). 11–19. 3 indexed citations
10.
Ramana, Kota V. & Krishan K. Kohli. (1996). Induction of Hepatic Cytochrome P450 by Phenobarbitone in Rhesus Monkey (Macaca Mulatta). Drug and Chemical Toxicology. 19(1-2). 97–107. 3 indexed citations
11.
Puri, Sanjeev & Krishan K. Kohli. (1995). Differences in Hepatic Drug Metabolizing Enzymes and their‐Response to Lindane in Rat, Rabbit and Monkey. Pharmacology & Toxicology. 77(2). 136–141. 12 indexed citations
12.
Kohli, Krishan K., et al.. (1994). Induction of hepatic microsomal cytochrome P450 by dexamethasone in rhesus monkey (Macaca mulatta).. PubMed. 33(6). 1135–43. 4 indexed citations
13.
14.
Kohli, Krishan K. & Joyce A. Goldstein. (1981). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and renal prostaglandin synthetase. Life Sciences. 29(3). 299–305. 4 indexed citations
15.
Kohli, Krishan K., B. N. Gupta, Phillip W. Albro, & James D. McKinney. (1981). Effects of inducers of drug metabolism enzymes on triglyceride and phospholipid biosynthesis. Chemico-Biological Interactions. 36(1). 117–121. 13 indexed citations
16.
Kohli, Krishan K., B. N. Gupta, Phillip W. Albro, Hasan Mukhtar, & James D. McKinney. (1979). Biochemical effects of pure isomers of hexachlorobiphenyl: Fatty livers and cell structure. Chemico-Biological Interactions. 25(2-3). 139–156. 35 indexed citations
17.
Kohli, Krishan K., Phillip W. Albro, & James D. McKinney. (1979). Radioisotope Dilution Assay (RIDA) for the Estimation of Polychlorinated Biphenyls (PCBs). Journal of Analytical Toxicology. 3(3). 125–128. 3 indexed citations
18.
Kohli, Krishan K., Farhan Asif Siddiqui, & T. A. Venkitasubramanian. (1977). Effect of dieldrin on the stability of lysosomes in the rat liver. Bulletin of Environmental Contamination and Toxicology. 18(5). 617–623. 5 indexed citations
19.
Kohli, Krishan K. & T. A. Venkitasubramanian. (1975). Dieldrin toxicity and in vivo incorporation of DL-[1-14C]leucine. Toxicology. 4(3). 389–391. 5 indexed citations
20.
Kohli, Krishan K., Sumati Bhatia, & T. A. Venkitasubramanian. (1975). Effect of dieldrin toxicity on acetate and palmitate metabolism in rat liver.. PubMed. 5(2). 119–25. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margarita G. Ladona Breakdown of academic impact, for papers by Burke Breakdown of academic impact, for papers by Ronald J. Gerson Breakdown of academic impact, for papers by Shunsuke Iwano Breakdown of academic impact, for papers by J Loeper Breakdown of academic impact, for papers by Peter H. Bach Breakdown of academic impact, for papers by Mikio Doy Breakdown of academic impact, for papers by A. Al‐Bader Breakdown of academic impact, for papers by José M. Pellegrino Breakdown of academic impact, for papers by Cécile Astre
Rankless by CCL
2026